For more information or confidential assistance
Call 800-306-3180

EMA Issues New Guidelines for Invokana

diabetes
On February 12, the European Medicines Agency issued a new set of recommendations to minimize the risk of diabetic ketoacidosis in patients taking SGLT2 inhibitors — including Invokana. SGLT2 inhibitors are a type of type 2 diabetes medication designed to help lower blood sugar in... Read More